An insightful article from the New York Times places women at the epicenter of the future of healthcare. Candesic’s Dr Michelle Tempest explains how gender inequality historically affected drug trials.

Is ‘Femtech’ an increasingly important segment of the healthcare market? Read the full article to find out.